{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:58:21Z","timestamp":1781081901908,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Monoglucosyl hesperidin promotes nitric oxide production in vascular endothelial cells and contributes to blood flow improvement and edema reduction. While preclinical studies in animal subjects have also suggested a role in promoting lymphatic drainage, its effect on human lymphatic function remains unexplored. Here, we examined the effect of monoglucosyl hesperidin intake (300\u00a0mg\/day) on the lymphatic system in a controlled trial in healthy human adults (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930). Thoracic duct diameter was assessed by high-frequency ultrasonography as a surrogate marker of central lymphatic flow. While no effect was detected in the full cohort, in the subgroup analysis of participants with no exercise habit, monoglucosyl hesperidin intake significantly increased or showed a trend toward an increase in the thoracic duct diameter (Variation maximum value in the amount of change and the rate of change were\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01 and\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01, respectively; Variation minimum value in the amount of change and the rate of change were\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.06 and\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01 respectively; ). This was consistent with the increase in lymph flow rate observed in previous animal studies, highlighting, for the first time, monoglucosyl hesperidin influencing the human lymphatic circulation function. In addition, the results suggested that thoracic duct ultrasonography had potential as a noninvasive biomarker for future interventional studies targeting lymphatic circulation function.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-36166-1","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:05:54Z","timestamp":1781078754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of monoglucosyl hesperidin on human lymphatic circulatory function: A randomized placebo-controlled, double-blind, crossover trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Akira","family":"Shinaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Karasudani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"36166_CR1","doi-asserted-by":"publisher","unstructured":"Kumar, S. & Pandey, A. K. Chemistry and biological activities of flavonoids: an overview. Scientific World Journal 162750; (2013). https:\/\/doi.org\/10.1155\/2013\/162750 (2013).","DOI":"10.1155\/2013\/162750"},{"key":"36166_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5115\/acb.19.189","volume":"52","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Benefits of hesperidin in central nervous system disorders: A review. Anat. Cell. Biology. 52, 369\u2013377. https:\/\/doi.org\/10.5115\/acb.19.189 (2019).","journal-title":"Anat. Cell. Biology"},{"key":"36166_CR3","doi-asserted-by":"publisher","first-page":"e26862","DOI":"10.1016\/j.heliyon.2023.e26862","volume":"10","author":"Z Ji","year":"2024","unstructured":"Ji, Z. et al. Recent Understanding of the mechanisms of the biological activities of hesperidin and Hesperetin and their therapeutic effects on diseases. Heliyon 10, e26862. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e26862 (2024).","journal-title":"Heliyon"},{"issue":"Suppl 1","key":"36166_CR4","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1177\/0003319701052001S07","volume":"52","author":"AA Ramelet","year":"2001","unstructured":"Ramelet, A. A. Clinical benefits of Daflon 500\u00a0mg in the most severe stages of chronic venous insufficiency. Angiology 52 (Suppl 1), S49\u2013S56 (2001).","journal-title":"Angiology"},{"key":"36166_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1021\/jf073250z","volume":"56","author":"L Liu","year":"2008","unstructured":"Liu, L., Xu, D. M. & Cheng, Y. Y. Distinct effects of naringenin and Hesperetin on nitric oxide production from endothelial cells. J. Agric. Food Chem. 56, 824\u2013829. https:\/\/doi.org\/10.1021\/jf073250z (2008).","journal-title":"J. Agric. Food Chem."},{"key":"36166_CR6","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.sjbs.2021.07.046","volume":"28","author":"KM Yap","year":"2021","unstructured":"Yap, K. M. et al. Hesperidin and its aglycone Hesperetin in breast cancer therapy: A review of recent developments and future prospects. Saudi J. Biol. Sci. 28, 6730\u20136747. https:\/\/doi.org\/10.1016\/j.sjbs.2021.07.046 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"36166_CR7","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3390\/nu14132647","volume":"14","author":"K Wdowiak","year":"2022","unstructured":"Wdowiak, K., Walkowiak, J., Pietrzak, R., Bazan-Wo\u017aniak, A. & Cielecka-Piontek, J. Bioavailability of hesperidin and its aglycone hesperetin-compounds found in citrus fruits as a parameter conditioning the pro-health potential (neuroprotective and antidiabetic activity)\u2013Mini-Review. Nutrients 14, 2647. https:\/\/doi.org\/10.3390\/nu14132647 (2022).","journal-title":"Nutrients"},{"key":"36166_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/BIR-140653","volume":"51","author":"MJ Simmonds","year":"2014","unstructured":"Simmonds, M. J., Detterich, J. A. & Connes, P. Nitric oxide, vasodilation and the red blood cell. Biorheology 51, 121\u2013134. https:\/\/doi.org\/10.3233\/BIR-140653 (2014).","journal-title":"Biorheology"},{"issue":"Suppl 1","key":"36166_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1538-7836.2009.03424.x","volume":"7","author":"WC Sessa","year":"2009","unstructured":"Sessa, W. C. Molecular control of blood flow and angiogenesis: role of nitric oxide. J. Thromb. Haemost. 7 (Suppl 1), 35\u201337. https:\/\/doi.org\/10.1111\/j.1538\u20137836.2009.03424.x (2009).","journal-title":"J. Thromb. Haemost."},{"issue":"3 Suppl 1","key":"36166_CR10","first-page":"36","volume":"14","author":"C Labrid","year":"1995","unstructured":"Labrid, C. A lymphatic function of Daflon 500 mg. Int. Angiol. 14 (3 Suppl 1), 36\u201338 (1995).","journal-title":"Int. Angiol."},{"key":"36166_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jmri.22230","volume":"32","author":"DX Yu","year":"2010","unstructured":"Yu, D. X., Ma, X. X., Zhang, X. M., Wang, Q. & Li, C. F. Morphological features and clinical feasibility of thoracic duct: detection with nonenhanced magnetic resonance imaging at 3.0 T. J. Magn. Reson. Imaging. 32, 94\u2013100. https:\/\/doi.org\/10.1002\/jmri.22230 (2010).","journal-title":"J. Magn. Reson. Imaging"},{"key":"36166_CR12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1148\/radiol.2523081033","volume":"252","author":"M Seeger","year":"2009","unstructured":"Seeger, M. et al. Terminal part of thoracic duct: high-resolution US imaging. Radiology 252, 897\u2013904. https:\/\/doi.org\/10.1148\/radiol.2523081033 (2009).","journal-title":"Radiology"},{"key":"36166_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2214\/ajr.165.4.7676982","volume":"165","author":"G Zironi","year":"1995","unstructured":"Zironi, G. et al. Sonographic assessment of the distal end of the thoracic duct in healthy volunteers and in patients with portal hypertension. Am. J. Roentgenol. 165, 863\u2013866. https:\/\/doi.org\/10.2214\/ajr.165.4.7676982 (1995).","journal-title":"Am. J. Roentgenol."},{"key":"36166_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ca.23801","volume":"35","author":"LR Hinton","year":"2002","unstructured":"Hinton, L. R. et al. The effect of respiration and body position on terminal thoracic duct diameter and the lymphovenous junction: an exploratory ultrasonography study. Clin. Anat. 35, 447\u2013453. https:\/\/doi.org\/10.1002\/ca.23801 (2002).","journal-title":"Clin. Anat."},{"key":"36166_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ca.23933","volume":"36","author":"A Kowalczyk","year":"2023","unstructured":"Kowalczyk, A., S\u0142ugocki, M. & Kole\u015bnik, A. Sonography for assessment of thoracic duct anatomy and physiology before and after meals. Clin. Anat. 36, 11\u201317. https:\/\/doi.org\/10.1002\/ca.23933 (2023).","journal-title":"Clin. Anat."},{"key":"36166_CR16","doi-asserted-by":"publisher","unstructured":"Shinaoka, A. & Kimata, Y. Lymphatic flow dynamics under exercise load assessed with thoracic duct ultrasonography. Scientific Reports. 24, 14323.; (2025). https:\/\/doi.org\/10.1038\/s41598-025-99416-8 (2025).","DOI":"10.1038\/s41598-025-99416-8"},{"key":"36166_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/10739680600893909","volume":"13","author":"JB Dixon","year":"2006","unstructured":"Dixon, J. B. et al. Lymph flow, shear stress, and lymphocyte velocity in rat mesenteric prenodal lymphatics. Microcirculation 13, 597\u2013610. https:\/\/doi.org\/10.1080\/10739680600893909 (2006).","journal-title":"Microcirculation"},{"key":"36166_CR18","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1113\/jphysiol.2001.016642","volume":"540","author":"AA Gashev","year":"2002","unstructured":"Gashev, A. A., Davis, M. J. & Zawieja, D. C. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J. Physiol. 540, 1023\u20131037. https:\/\/doi.org\/10.1113\/jphysiol.2001.016642 (2002).","journal-title":"J. Physiol."},{"key":"36166_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbrc.2019.10.199","volume":"521","author":"A Ota-Kontani","year":"2020","unstructured":"Ota-Kontani, A., Hirata, H., Ogura, M., Tsuchiya, Y. & Harada-Shiba, M. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin. Biochem. Biophys. Res. Commun. 521, 861\u2013867. https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.199 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36166_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2131\/fts.6.299","volume":"8","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto, S., Hashimoto, T., Ushio, C., Namekawa, K. & Richards, B. Glucosyl hesperidin: safety studies. Fundamental Toxicol. Sci. 8, 299\u2013317. https:\/\/doi.org\/10.2131\/fts.6.299 (2019).","journal-title":"Fundamental Toxicol. Sci."},{"key":"36166_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1271\/bbb.50657","volume":"70","author":"M Yamada","year":"2006","unstructured":"Yamada, M. et al. Bioavailability of glucosyl hesperidin in rats. Biosci. Biotechnol. Biochem. 70, 1386\u20131394. https:\/\/doi.org\/10.1271\/bbb.50657 (2006).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"36166_CR22","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.xphs.2021.02.030","volume":"110","author":"F Zeng","year":"2021","unstructured":"Zeng, F. et al. Nanoemulsion for improving the oral bioavailability of hesperetin: formulation optimization and absorption mechanism. J. Pharm. Sci. 110, 2555\u20132561. https:\/\/doi.org\/10.1016\/j.xphs.2021.02.030 (2021).","journal-title":"J. Pharm. Sci."},{"key":"36166_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2170\/jjphysiol.53.157","volume":"53","author":"H Tsunemoto","year":"2003","unstructured":"Tsunemoto, H., Ikomi, F. & Ohhashi, T. Flow-mediated release of nitric oxide from lymphatic endothelial cells of pressurized canine thoracic duct. Jpn. J. Physiol. 53, 157\u2013163. https:\/\/doi.org\/10.2170\/jjphysiol.53.157 (2003).","journal-title":"Jpn. J. Physiol."},{"key":"36166_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1113\/jphysiol.2006.115212","volume":"575","author":"OY Gasheva","year":"2006","unstructured":"Gasheva, O. Y., Zawieja, D. C. & Gashev, A. A. Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct. J. Physiol. 575, 821\u2013832. https:\/\/doi.org\/10.1113\/jphysiol.2006.115212 (2006).","journal-title":"J. Physiol."},{"key":"36166_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/01.RES.0000135549.72828.24","volume":"95","author":"J Hagendoorn","year":"2004","unstructured":"Hagendoorn, J. et al. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circul. Res. 95, 204\u2013209. https:\/\/doi.org\/10.1161\/01.RES.0000135549.72828.24 (2004).","journal-title":"Circul. Res."},{"key":"36166_CR26","doi-asserted-by":"publisher","first-page":"20200598","DOI":"10.1098\/rsif.2020.0598","volume":"17","author":"MS Razavi","year":"2020","unstructured":"Razavi, M. S., Dixon, J. B. & Gleason, R. L. Characterization of rat tail lymphatic contractility and biomechanics: incorporating nitric oxide-mediated vasoregulation. J. Royal Soc. Interface. 17, 20200598. https:\/\/doi.org\/10.1098\/rsif.2020.0598 (2020).","journal-title":"J. Royal Soc. Interface"},{"key":"36166_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/lrb.2022.0072","volume":"21","author":"T Ohhashi","year":"2023","unstructured":"Ohhashi, T., Kawai, Y., Maejima, D., Hayashi, M. & Watanabe-Asaka, T. Physiological roles of lymph flow-mediated nitric oxide in lymphatic system. Lymphatic Res. Biology. 21, 253\u2013261. https:\/\/doi.org\/10.1089\/lrb.2022.0072 (2023).","journal-title":"Lymphatic Res. Biology"},{"key":"36166_CR28","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish, B. H. et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34, 2\u201311 (2001).","journal-title":"Lymphology"},{"issue":"2","key":"36166_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/BD-201008","volume":"40","author":"AJ Forte","year":"2021","unstructured":"Forte, A. J. et al. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema. Breast Dis. 40 (2), 85\u201393 (2021).","journal-title":"Breast Dis."},{"key":"36166_CR30","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.3390\/ijms23126621","volume":"23","author":"BH Duhon","year":"2022","unstructured":"Duhon, B. H., Phan, T. T., Taylor, S. H., Crescenzi, R. L. & Rutkowski, J. M. Current mechanistic Understandings of lymphedema and lipedema: Tales of fluid, fat, and fibrosis. Int. J. Mol. Sci. 23, 6621. https:\/\/doi.org\/10.3390\/ijms23126621 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"36166_CR31","doi-asserted-by":"publisher","first-page":"828513","DOI":"10.3389\/fphar.2022.828513","volume":"13","author":"S Brown","year":"2022","unstructured":"Brown, S. et al. Pharmacological treatment of secondary lymphedema. Front. Pharmacol. 13, 828513. https:\/\/doi.org\/10.3389\/fphar.2022.828513 (2022).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"36166_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.ejcn.1602543","volume":"61","author":"FI Kanaze","year":"2007","unstructured":"Kanaze, F. I., Bounartzi, M. I., Georgarakis, M. & Niopas, I. Pharmacokinetics of the citrus Flavanone aglycones Hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 61 (4), 472\u2013427. https:\/\/doi.org\/10.1038\/sj.ejcn.1602543 (2007).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"36166_CR33","first-page":"211","volume":"47","author":"Y Nakamura","year":"2019","unstructured":"Nakamura, Y. et al. Evaluation of the effect of Lemon-Derived enzymatically modified hesperidin on reducing facial swelling in healthy Japanese adults: A Randomized, Placebo-Controlled, Double-Blind, crossover trial. J. Pharmacol. Therapy. 47 (2), 211\u2013228 (2019).","journal-title":"J. Pharmacol. Therapy"},{"key":"36166_CR34","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/nu11081898","volume":"11","author":"FJ Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez, F. J., Cristian Mar\u00edn, C., Carlos, J., Rubio, J. A. & Alcaraz, P. E. Acute effects of hesperidin in Oxidant\/Antioxidant state markers and performance in amateur cyclists. Nutrients 11, 1898. https:\/\/doi.org\/10.3390\/nu11081898 (2019).","journal-title":"Nutrients"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36166-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:05:55Z","timestamp":1781078755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36166-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36166"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36166-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. A. S., and Y. K. are affiliated with Okayama University, which received research funding from Suntory Beverage & Food Ltd. T. H., K. T., Y. K., S. M., Y. T., T. M. and A. M. are employees of Suntory Beverage & Food Ltd. The authors declare that there are no other conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr. A. S., and Y. K. are affiliated with Okayama University, which received research funding from Suntory Beverage & Food Ltd. T. H., K. T., Y. K., S. M., Y. T., T. M. and A. M. are employees of Suntory Beverage & Food Ltd. The authors declare that there are no other conflicts of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial and competing interest disclosure statement"}}],"article-number":"18010"}}